Inattention News and Research

RSS
Attention deficit hyperactivity disorder costs the U.S. $77 billion each year

Attention deficit hyperactivity disorder costs the U.S. $77 billion each year

FDA approval for chewable ADHD tablets

FDA approval for chewable ADHD tablets

Stroke severity is the predominant predictor of discharge destination

Stroke severity is the predominant predictor of discharge destination

Drug helps children with attention deficit/hyperactivity disorder (ADHD)

Drug helps children with attention deficit/hyperactivity disorder (ADHD)